Formulations of human growth hormone comprising a non-naturally encoded amino acid

Details for Australian Patent Application No. 2005322019 (hide)

Owner Ambrx, Inc.

Inventors Buechler, Ying; Hays Putnam, Anna Maria A; Litzinger, David C

Agent FB Rice

Pub. Number AU-B-2005322019

PCT Pub. Number WO2006/071840

Priority 60/680,617 13.05.05 US; 60/728,035 17.10.05 US; 60/638,616 22.12.04 US

Filing date 21 December 2005

Wipo publication date 6 July 2006

Acceptance publication date 26 August 2010

International Classifications

A61K 38/00 (2006.01) Medicinal preparations containing peptides

Event Publications

7 June 2007 Amendment Made

  The nature of the amendment is: Amend the co-inventor name from Hays, Anna-Maria to Hays Putnam, Anna Maria A 2006

14 June 2007 PCT application entered the National Phase

  PCT publication WO2006/071840 Priority application(s): WO2006/071840

26 August 2010 Application Accepted

  Published as AU-B-2005322019

23 December 2010 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005322023-Oxygen-impervious packaging and methods for storing thyroid hormone

2005322015-Methods for inhibiting a decline in learning and/or memory in animals